The German Center for Pediatric and Adolescent Rheumatology in Garmisch-Partenkirchen is the largest specialized center for the treatment of children and adolescents with rheumatic diseases and chronic pain syndromes in Europe.

During the past decade, Deutsches Zentrum für Kinder- und Jugendrheumatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" are "Juvenile Idiopathic Arthritis" (2 trials), "Arthritis Juvenile Idiopathic" (1 trials) and "Uveitis" (1 trials). Many other conditions were trialed in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" in a lesser frequency.

Most popular intervention types in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cyclosporine A" (1 trials), "In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio" (1 trials), "In open-label phase: treatment with tofacitinib" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Deutsches Zentrum für Kinder- und Jugendrheumatologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Deutsches Zentrum für Kinder- und Jugendrheumatologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Deutsches Zentrum für Kinder- und Jugendrheumatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Deutsches Zentrum für Kinder- und Jugendrheumatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".